Skip to content

Maple Syrup Urine Disease Type 1a C1855369

Published: July 22, 2026Updated: August 20, 2026

A metabolic disorder where the body cannot process certain amino acids, causing sweet-smelling urine. Typically detected at birth. Requires lifelong specialized diet and careful monitoring.

Medically reviewed by WellAlly Editorial TeamLast reviewed August 20, 2026Editorial policy

Key facts at a glance

ICD-10
E88.9
ICD-11
5A00.0
Body system
metabolic
Severity
severe
Chronic
true

Signs and symptoms

Common signs and symptoms that may indicate this condition.

Warning signs - seek immediate care

!

Encephalopathy

!

Seizures

Fatigue or weight changes

(metabolic)

Significant symptoms that substantially affect daily functioning.

Frequency: Common at all stages

Maple syrup odor of urine

(metabolic)

Feeding difficulties

(gastrointestinal)

Diagnosis and tests

How this condition is diagnosed and what test results mean.

Initial screening tests

1

Standard diagnostic workup

Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]

Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]

Treatment options

Evidence-based approaches to managing this condition.

First-line treatments

1

Branched-chain amino acid restricted diet

Lifelong dietary management restricting leucine, isoleucine, and valine through specialized formulas and careful food selection to prevent toxic metabolite accumulation.

dietary
2

Medication management with follow-up care

Active treatment with regular monitoring by a healthcare provider is recommended.

medication
3

Thiamine supplementation trial

High-dose vitamin B1 supplementation to test for thiamine responsiveness, which may improve residual enzyme activity in some patients with MSUD.

medication

Additional treatment options

Acute metabolic crisis management

Emergency intervention during metabolic decompensation including IV glucose, lipid emulsion, and amino acid-free parenteral nutrition to reverse catabolism.

procedure

Metabolic parameter monitoring

Regular measurement of branched-chain amino acids, alloisoleucine, and biochemical markers to guide dietary adjustments and assess metabolic control.

monitoring

Liver transplantation evaluation

Consideration of liver transplant in severe, refractory cases to provide enzyme source capable of metabolizing branched-chain amino acids systemically.

surgical

When to seek medical help

Recognize when you need immediate medical attention.

See a doctor within 24 hours

Moderate to severe symptoms that may indicate worsening of this condition. Prompt medical evaluation is recommended.

Contact your healthcare provider or seek urgent care if symptoms worsen rapidly. Go to the emergency department for life-threatening symptoms.

Frequently asked questions

Common questions about this topic.

Q

What is Maple Syrup Urine Disease Type 1a C1855369?

Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]

general

Medication Comparisons

Compare medications used to treat Maple Syrup Urine Disease Type 1a C1855369. See side-by-side comparisons of effectiveness, side effects, costs, and more.

View Medication Comparisons

This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.

Medical Disclaimer

This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.

If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.

Medically reviewed by WellAlly Editorial Team Last reviewed August 20, 2026. · Read our editorial policy